DELCATH SYSTEMS, INC.

Develops targeted chemotherapy delivery systems for treating primary and metastatic liver cancers.

DCTH | NDAQ

Overview

Corporate Details

ISIN(s):: US24661P8077
LEI:
Country:: United States of America
Address:: 566 QUEENSBURY AVENUE, 12804 QUEENSBURY
Website:: https://delcath.com/
Sector:: Manufacturing
Industry:: Manufacture of medical and dental instruments and supplies

Description

Delcath Systems, Inc. is a commercial-stage, interventional oncology company focused on treating primary and metastatic liver cancers. The company develops and commercializes specialty pharmaceutical and medical device products based on its proprietary percutaneous hepatic perfusion (PHP) technology. This minimally-invasive procedure is designed to deliver high-dose chemotherapy directly to the liver while controlling systemic side effects. Its flagship products are the HEPZATO KIT™, recently FDA-approved in the U.S. for treating metastatic uveal melanoma, and the CHEMOSAT® Hepatic Delivery System, a medical device available in Europe. Delcath aims to provide targeted, minimally-invasive treatment options for patients with liver-dominant cancers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all DELCATH SYSTEMS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DELCATH SYSTEMS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for DELCATH SYSTEMS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
enVVeno Medical Corp Develops bioprosthetic venous valves for treating severe Chronic Venous Insufficiency.	United States of America	NVNO
Episurf Develops patient-specific orthopedic implants and surgical tools for joint degeneration.	Sweden	EPIS
Epitomee Medical Ltd. Develops ingestible therapeutic devices for weight management and targeted drug delivery.	Israel	EPIT
EssilorLuxottica Global leader in designing, manufacturing & distributing ophthalmic lenses, frames & sunglasses.	France	EL
ESTABLISHMENT LABS HOLDINGS INC. A medical tech company developing science-based Femtech solutions for breast aesthetics & reconstruction.	United States of America	ESTA
Etropal AD Manufactures disposable medical products, specializing in hemodialysis equipment and consumables.	Bulgaria	ETR
Euromedis Groupe Manufactures & distributes medical devices and provides home healthcare for facilities & patients.	France	ALEMG
EXAGEN INC. Provides advanced biomarker tests for diagnosing and monitoring chronic autoimmune diseases.	United States of America	XGN
FEMASYS INC Develops minimally invasive gynecological solutions for diagnostics, fertility, and birth control.	United States of America	FEMY
Forward Industries, Inc. End-to-end design & manufacturing for medical/tech IoT, wearables, and carrying solutions.	United States of America	FORD